Latest News

December 20, 2013
Inside UCSF takes a quick look at some of the biggest stories of 2013 that highlight the University and the campus community.
December 18, 2013
Experts across UCSF weigh in on what some of 2014's top trends are in research and patient care.
November 27, 2013
UCSF is one of the first pharmacy schools in the nation to offer its students genetic testing for drug response. It’s just one way they're learning about the potential of precision medicine.
November 15, 2013
Precision Medicine Pillar No. 5: Omics Medicine. Molecular biologist Nevan Krogan's work is not only illuminating how genes and proteins function, it's also shedding light on the underlying biology of disease for each person.
November 15, 2013
Precision Medicine Pillar No. 4: Computational Health Sciences. Computationally intensive approaches are used to analyze and cross-analyze large but discrete collections of data, such as patient health histories and genetic makeup.
November 15, 2013
Precision Medicine Pillar No. 3: Clinical Discovery. Researchers are taking vast amounts of patient data, often collected through first-ever clinical studies, and putting it into tools like MS Bioscreen that have a direct impact on patient care.
November 15, 2013
Precision Medicine Pillar No. 2: Basic Discovery. The long path to developing potent new treatments often starts with an observation in the lab that then leads to a question about a fundamental life process.
November 15, 2013
Today, with a host of tools garnered from precision medicine, patients can benefit from precise and effective therapies for some of the world's most daunting illnesses. UCSF Magazine explores the promise of precision medicine.
November 15, 2013
Precision Medicine Pillar No. 6: Digital Health. The Center for Digital Health Innovation shepherds the development of digital health innovations created at UCSF and validates the effectiveness of devices from both inside and outside the institution.
October 16, 2013
A UCSF-led team of scientists has discovered that a gene mutation found in some bladder cancers is indicative of low-risk tumors that are unlikely to recur or progress after surgery.

Pages